ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2014

Jun 16, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2014-06-12

Reporting Person: JACOBS CINDY (EVP, CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-12	Restricted Stock Unit (RSU)	$	A	20000	Acquired		Common Stock (20000)	Direct
2014-06-12	Restricted Stock Unit (RSU)	$	A	20000	Acquired	2016-07-30	Common Stock (20000)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock at settlement.

F2: Pursuant to the terms of the RSU, the total underlying shares vest in four equal annual installments on the later of (i) each anniversary of the grant date and (ii) the first day thereafter during which the issuer's trading window is open, subject to the reporting person's provision of service to the issuer on each vesting date.

F3: The RSUs expire 30 days from the date they vest.

F4: Pursuant to the terms of the RSU, the total underlying shares vest if and when certain performance criteria relating to the issuer are met, subject to the reporting person's provision of service to the issuer on each vesting date, although less than 100% of the total shares may vest upon the achievement of certain, but not all, of the milestones.